Beam Therapeutics financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

빔 테라퓨틱스NASDAQ:BEAM · Nasdaq · Healthcare

$25.67+4.78%

2026-10-05 close · prelim

Beam Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $64M. 2024 operating profit was −$416M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy